Biological Skin Substitutes Market to be Dominated by the Human Donor Tissue-Derived Products through 2028
Increasing adoption of regenerative medicine techniques and rising
incidences of chronic wounds is expected to drive the growth of global Biological
Skin Substitutes market during the forecast period, 2024-2028.
According to
TechSci Research report, “Biological
Skin Substitutes Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Biological Skin Substitutes Market is expected to grow during the forecast period of 2024-2028. owing to the increasing incidences of chronic wounds,
growing geriatric population, and increasing adoption of regenerative medicine
techniques.
However, there are several challenges that will
hamper the growth of Biological Skin Substitutes market in coming years. These
challenges are high cost of product, regulatory issues, lack of awareness, and
competition from alternative treatment modalities.
The COVID-19 pandemic has had a significant impact
on the global biological skin substitutes market. While the market was growing
steadily prior to the pandemic, the outbreak has led to a number of challenges
and disruptions, including supply chain disruptions, decreased demand, and
delays in clinical trials and regulatory approvals.
One of the biggest impacts of the pandemic on the
biological skin substitutes market has been the disruption to the global supply
chain. Many manufacturers of biological skin substitutes rely on raw materials
from countries that were hit hard by the pandemic, such as China and India. As
the countries-imposed lockdowns and restrictions on travel and trade, it became
more difficult for manufacturers to obtain the materials they needed, leading
to supply shortages and delays.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global
Biological Skin Substitutes Market"
Global Biological Skin Substitutes market can be segmented on the basis of type, application, end user, and
region.
Based on type, the market can be further divided into human donor
tissue-derived products, acellular animal derived products, and biosynthetic products.
Human Donor Tissue-derived products are expected to dominate the global
biological skin substitute market during the forecast period owing to their
high success rate. Human donor tissue-derived products have a high success rate
in terms of engraftment and healing. This is due to their similarity to human
skin and their ability to integrate into the recipient's tissue. Human donor
tissue-derived products have been used for skin replacement for decades and are
well-established as a safe and effective treatment option. This has helped to
build trust and confidence in their use among physicians and patients. Human
donor tissue-derived products are often less expensive than other options, such
as synthetic skin substitutes. This makes them a more accessible option for
patients who may not be able to afford more expensive treatments.
Global biological skin substitutes market is divided into chronic wounds and
acute wounds, based on application. Chronic wounds are expected to dominate the
global market of biological skin substitutes in coming years. Chronic wounds,
such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are a
growing healthcare concern around the world. These wounds can be difficult to
treat and may take months or even years to heal. In recent years, there has
been a growing interest in the use of biological skin substitutes to help
accelerate wound healing and reduce the risk of infection. Additionally,
advances in technology and research have led to the development of increasingly
sophisticated biological skin substitutes that are better able to meet the
unique needs of chronic wounds. For example, some products contain growth
factors that stimulate the growth of new tissue, while others incorporate
antimicrobial agents to reduce the risk of infection. As these products become
more widely available and more effective, they are likely to become the
treatment of choice for many physicians and patients.
Major companies
operating in global Biological Skin Substitutes market are:
- Smith & Nephew, plc
- 3M Company
- Organogenesis, Inc.
- Stratatech Corporation
- Integra LifeSciences Corporation
- Tissue Regenix Group
- Mimedx Group
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The global
biological skin substitutes market is a rapidly growing industry that includes
a variety of products designed to promote wound healing and tissue
regeneration. These products are derived from a variety of sources, including
human donor tissue, animal tissue, and synthetic materials, and are used to
treat a wide range of conditions, including burns, chronic wounds, and surgical
wounds. While the market has faced some challenges in recent years, including
disruptions to the global supply chain and decreased demand due to the COVID-19
pandemic, it is expected to continue to grow in the coming years, driven by
increasing demand for effective wound care treatments and advances in
technology and research,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research- based global management consulting firm.
“Biological Skin Substitutes Market- Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Human Donor
Tissue-Derived Products, Acellular Animal Derived Products, Biosynthetic
Products), By Application (Chronic Wounds v/s Acute Wounds), By End User
(Hospitals & Clinics, Ambulatory Care Centers, Others), Region and
Competition”, has evaluated the future growth potential of Global Biological Skin Substitutes Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global
Biological Skin Substitutes Market.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com